Varian Medical Systems

Global Proton Therapy Market 2013-2018 & 2019-2023 - Key Players are IBA Proton Therapy, Hitachi, Varian Medical Systems, Mevion Medical Systems, Advanced Oncotherapy & ProTom International

Retrieved on: 
Thursday, February 7, 2019
Radiation therapy, Medical physics, Proton, Proton therapy, Varian Medical Systems, PROTON Holdings, Companies, Medicine, Spaceflight

Global proton therapy market is projected to display a healthy growth represented by a vigorous CAGR of 14.53% during 2018 - 2023.

Key Points: 
  • Global proton therapy market is projected to display a healthy growth represented by a vigorous CAGR of 14.53% during 2018 - 2023.
  • Amongst the regions, North America accounts for the largest regional share in the global proton therapy market in 2018.
  • Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global proton therapy market.
  • Some of the key players operating in this market include IBA Proton Therapy, Inc., Hitachi, Varian Medical Systems, Mevion Medical Systems, Advanced Oncotherapy plc, ProTom International, etc.

The Global Radiation Therapy Market with Focus on Linear Accelerator (LINAC) 2019-2023 - Key Players are Ion Beam Applications, Varian Medical Systems, Accuray and Elekta - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 5, 2019
Health, Oncology, Pharmaceutical, Medicine, Physics, Physical sciences, Radiation therapy, Medical physics, Accelerator physics, Radiobiology, Linear particle accelerator, Proton therapy, Varian Medical Systems, Elekta, Hera

The "Global Radiation Therapy Market with Focus on Linear Accelerator (LINAC): Industry Analysis & Outlook (2019-2023)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Radiation Therapy Market with Focus on Linear Accelerator (LINAC): Industry Analysis & Outlook (2019-2023)" report has been added to ResearchAndMarkets.com's offering.
  • The four major players: Ion Beam Applications, Varian Medical Systems, Elekta AB and Accuray, are profiled along with their key financials and strategies for growth.
  • Further, the external beam is classified into three different segments, namely; LINAC, proton beam therapy and compact advanced radiation therapy.
  • However, the expansion of radiation therapy market is hindered by stringent regulations, barriers to implementation and harsh side effects of radiation therapy.

Oncology Information Systems Market Worth $3.4 Billion by 2026: Grand View Research, Inc.

Retrieved on: 
Tuesday, February 5, 2019
Elekta, Varian Medical Systems, Cerner, RaySearch Laboratories, Companies, Economy of Sweden, Health

SAN FRANCISCO, Feb. 5, 2019 /PRNewswire/ -- The global oncology information systems market size is expected to reach USD 3.4 billion by 2026, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Feb. 5, 2019 /PRNewswire/ -- The global oncology information systems market size is expected to reach USD 3.4 billion by 2026, according to a new report by Grand View Research, Inc.
  • Various government initiatives and increasing healthcare expenditure are anticipated to drive the regional growth
    Few key players operating in the oncology information systems market are Elekta AB, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories and Flatiron.
  • Such initiatives are anticipated to propel the oncology information system market during the forecast period.
  • Grand View Research has segmented the global oncology information systems market on the basis of products and services, application, and region:
    Oncology Information Systems Products and Services Outlook (Revenue, USD Billion, 2014 - 2026)

Oncology Information Systems Market Worth $3.4 Billion by 2026: Grand View Research, Inc.

Retrieved on: 
Tuesday, February 5, 2019
Elekta, Varian Medical Systems, Cerner, RaySearch Laboratories, Companies, Economy of Sweden, Health

SAN FRANCISCO, Feb. 5, 2019 /PRNewswire/ -- The global oncology information systems market size is expected to reach USD 3.4 billion by 2026, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Feb. 5, 2019 /PRNewswire/ -- The global oncology information systems market size is expected to reach USD 3.4 billion by 2026, according to a new report by Grand View Research, Inc.
  • Various government initiatives and increasing healthcare expenditure are anticipated to drive the regional growth
    Few key players operating in the oncology information systems market are Elekta AB, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories and Flatiron.
  • Such initiatives are anticipated to propel the oncology information system market during the forecast period.
  • Grand View Research has segmented the global oncology information systems market on the basis of products and services, application, and region:
    Oncology Information Systems Products and Services Outlook (Revenue, USD Billion, 2014 - 2026)

Varian Installs Gantry for ProBeam Compact Proton Therapy System at New Treatment Center in Singapore

Retrieved on: 
Monday, January 21, 2019
Radiation therapy, Medicine, Medical physics, Health, Proton therapy, Therapy, Gantry, PROTON Holdings, Varian Medical Systems, Pencil-beam scanning

The gantry is a core piece of equipment of the ProBeam proton therapy system, and its installation is a key milestone for every new proton therapy center.

Key Points: 
  • The gantry is a core piece of equipment of the ProBeam proton therapy system, and its installation is a key milestone for every new proton therapy center.
  • Varian will also provide its Eclipse treatment planning system training environment for use by Proton Therapy Pte., Ltd.at its new Advanced Medicine Training Centre.
  • The Varian ProBeam Compact system is a single-room system equipped with a 360-degree gantry for intensity modulated proton therapy (IMPT).
  • Proton Therapy Pte., Ltd. will provide proton beam therapy treatment in Singapore.

First Cancer Patients in Taiwan Treated with Varian HyperArc High-Definition Radiotherapy

Retrieved on: 
Thursday, January 17, 2019
Radiobiology, Medicine, Radiation therapy, Neurosurgery, Radiosurgery, Medical physics, Geography of California, Palo Alto, California, Varian Medical Systems

PALO ALTO, Calif., Jan. 17, 2019 /PRNewswire/ --Varian (NYSE: VAR) announced 10 patients at the Chi Mei Medical Center with brain lesions became the first patients in Taiwan to be treated using the company's HyperArc High Definition Radiotherapy (HDRT), a new type of radiosurgery treatment solution.

Key Points: 
  • PALO ALTO, Calif., Jan. 17, 2019 /PRNewswire/ --Varian (NYSE: VAR) announced 10 patients at the Chi Mei Medical Center with brain lesions became the first patients in Taiwan to be treated using the company's HyperArc High Definition Radiotherapy (HDRT), a new type of radiosurgery treatment solution.
  • "We are excited that HyperArc treatments have begun in Taiwan," said Christina Lin, managing director Taiwan for Varian's Oncology Systems business.
  • For more information on the HyperArc solution, visit www.varian.com/hyperarc
    Varian is a leader in developing and delivering cancer care solutions and is focused on creating a world without fear of cancer.
  • Headquartered in Palo Alto, California, Varian employs approximately 7,000 people around the world.For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Paul Scherrer Institute Utilizing Varian Software Solution for Advanced Proton Therapy Treatments

Retrieved on: 
Tuesday, December 11, 2018
Radiation therapy, Medical physics, Medicine, Health, Physics, Proton therapy, Paul Scherrer Institute, Radiation treatment planning, Palo Alto, California, Therapy, Varian Medical Systems, Pencil-beam scanning

PALO ALTO, Calif., Dec. 11, 2018 /PRNewswire/ --Varian (NYSE: VAR) today announced the Paul Scherrer Institute (PSI) Center for Proton Therapy in Switzerland has begun utilizing Varian's Eclipse treatment planning system for intensity modulated proton therapy (IMPT) treatments.

Key Points: 
  • PALO ALTO, Calif., Dec. 11, 2018 /PRNewswire/ --Varian (NYSE: VAR) today announced the Paul Scherrer Institute (PSI) Center for Proton Therapy in Switzerland has begun utilizing Varian's Eclipse treatment planning system for intensity modulated proton therapy (IMPT) treatments.
  • The Eclipse treatment planning software creates an optimized treatment plan based on a physician's dose instructions, and information about the size, shape, and location of the tumor to be treated with proton therapy.
  • PSI delivered its first patient treatments in July 2018 based on plans developed in the Eclipse system.
  • Headquartered in Palo Alto, California, Varian employs approximately 7,000 people around the world.For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Varian-Equipped Emory Proton Therapy Center Opens

Retrieved on: 
Thursday, December 6, 2018
Radiation therapy, Health, Medical physics, Medicine, Proton, Proton therapy, Winship Cancer Institute, Therapy, Varian Medical Systems

PALO ALTO, Calif., Dec. 6, 2018 /PRNewswire/ --At a ribbon-cutting ceremony today in Atlanta, Georgia, the Varian-equipped Emory Proton Therapy Center officially opened.

Key Points: 
  • PALO ALTO, Calif., Dec. 6, 2018 /PRNewswire/ --At a ribbon-cutting ceremony today in Atlanta, Georgia, the Varian-equipped Emory Proton Therapy Center officially opened.
  • Four of the rooms include 360-degree rotational gantries offering image-guided intensity modulated proton therapy (IMPT), and the fifth room is dedicated for fixed beam treatments.
  • "The opening of the Emory Proton Therapy Center brings a powerful new cancer treatment option to the citizens of Georgia and expands the resources for comprehensive cancer care within Winship Cancer Institute,"said Mark McDonald, MD, medical director of the Emory Proton Therapy Center.
  • "The opening of the Emory Proton Therapy Center is another important step in the growing global availability of advanced cancer treatment technologies like proton therapy," said Kolleen Kennedy, chief growth officer and president, Proton Solutions at Varian.

HollandPTC Opens with ProBeam System from Varian

Retrieved on: 
Friday, November 30, 2018
Radiation therapy, Medical physics, Geography of California, Palo Alto, California, Silicon Valley, Proton therapy, California, Medicine, Varian Associates, Varian Medical Systems

PALO ALTO, Calif., Nov. 30, 2018 /PRNewswire/ --HollandPTC in Delft, Netherlands, opened today equipped with the ProBeam proton therapy system from Varian (NYSE: VAR).

Key Points: 
  • PALO ALTO, Calif., Nov. 30, 2018 /PRNewswire/ --HollandPTC in Delft, Netherlands, opened today equipped with the ProBeam proton therapy system from Varian (NYSE: VAR).
  • Varian's ProBeam system offers fully-integrated IMPT to enable more efficient adaptive proton therapy.
  • "We now have the opportunity to offer this advanced treatment technology from Varian and make a positive impact on many more lives.
  • Headquartered in Palo Alto, California, Varian employs approximately 7,000 people around the world.For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Global $4.95 Billion Image-guided Therapy Systems Market 2016-2018 & 2018-2025

Retrieved on: 
Wednesday, November 7, 2018
Medicine, Brainlab, Stryker Corporation, Medtronic, Varian Medical Systems, Analogic Corporation, Minimally invasive procedures, Varian, Health

Growing geriatric population base and cases of chronic diseases are expected to boost the market demand.

Key Points: 
  • Growing geriatric population base and cases of chronic diseases are expected to boost the market demand.
  • Other factors propelling the market growth include rising preference for minimally invasive surgeries and technological advancements in image-guided therapy systems.
  • Various initiatives undertaken in the area of cancer radiotherapy is also one of the important factors driving the market.
  • Analogic Corporation, Varian Medical Systems, Inc., Brainlab AG, Medtronic PLC, and Stryker Corp. are several other prominent companies in the market.